_version_ 1784730658649669632
author Vuitton, Lucine
Bourrier, Anne
Uzzan, Mathieu
Nachury, Maria
Amiot, Aurelien
Roblin, Xavier
Allez, Matthieu
Altwegg, Romain
Vidon, M.M.
Bourreille, Arnaud
Serrero, Melanie
Pelletier, Anne-Laure
Filippi, Jerome
Gilletta, Cyrielle
Simon, Marion
Laharie, David
Nahon, Stephane
Duveau, Nicolas
Biron, Amelie
Viennot, Stephanie
Abitbol, Vered
Elgharabawy, Yasmine
Peyrin-Biroulet, Laurent
author_facet Vuitton, Lucine
Bourrier, Anne
Uzzan, Mathieu
Nachury, Maria
Amiot, Aurelien
Roblin, Xavier
Allez, Matthieu
Altwegg, Romain
Vidon, M.M.
Bourreille, Arnaud
Serrero, Melanie
Pelletier, Anne-Laure
Filippi, Jerome
Gilletta, Cyrielle
Simon, Marion
Laharie, David
Nahon, Stephane
Duveau, Nicolas
Biron, Amelie
Viennot, Stephanie
Abitbol, Vered
Elgharabawy, Yasmine
Peyrin-Biroulet, Laurent
author_sort Vuitton, Lucine
collection PubMed
description
format Online
Article
Text
id pubmed-9212677
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92126772022-06-22 Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS Vuitton, Lucine Bourrier, Anne Uzzan, Mathieu Nachury, Maria Amiot, Aurelien Roblin, Xavier Allez, Matthieu Altwegg, Romain Vidon, M.M. Bourreille, Arnaud Serrero, Melanie Pelletier, Anne-Laure Filippi, Jerome Gilletta, Cyrielle Simon, Marion Laharie, David Nahon, Stephane Duveau, Nicolas Biron, Amelie Viennot, Stephanie Abitbol, Vered Elgharabawy, Yasmine Peyrin-Biroulet, Laurent Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212677/ http://dx.doi.org/10.1016/S0016-5085(22)61421-5 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Vuitton, Lucine
Bourrier, Anne
Uzzan, Mathieu
Nachury, Maria
Amiot, Aurelien
Roblin, Xavier
Allez, Matthieu
Altwegg, Romain
Vidon, M.M.
Bourreille, Arnaud
Serrero, Melanie
Pelletier, Anne-Laure
Filippi, Jerome
Gilletta, Cyrielle
Simon, Marion
Laharie, David
Nahon, Stephane
Duveau, Nicolas
Biron, Amelie
Viennot, Stephanie
Abitbol, Vered
Elgharabawy, Yasmine
Peyrin-Biroulet, Laurent
Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
title Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
title_full Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
title_fullStr Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
title_full_unstemmed Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
title_short Su1499: IMMUNOMODULATORS ARE PROTECTIVE AGAINST SEVERE COVID 19: RESULTS FROM A LARGE MULTICENTRE COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS
title_sort su1499: immunomodulators are protective against severe covid 19: results from a large multicentre cohort of inflammatory bowel disease patients
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212677/
http://dx.doi.org/10.1016/S0016-5085(22)61421-5
work_keys_str_mv AT vuittonlucine su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT bourrieranne su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT uzzanmathieu su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT nachurymaria su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT amiotaurelien su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT roblinxavier su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT allezmatthieu su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT altweggromain su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT vidonmm su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT bourreillearnaud su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT serreromelanie su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT pelletierannelaure su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT filippijerome su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT gillettacyrielle su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT simonmarion su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT lahariedavid su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT nahonstephane su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT duveaunicolas su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT bironamelie su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT viennotstephanie su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT abitbolvered su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT elgharabawyyasmine su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients
AT peyrinbirouletlaurent su1499immunomodulatorsareprotectiveagainstseverecovid19resultsfromalargemulticentrecohortofinflammatoryboweldiseasepatients